Internal radiation therapy of 131 I- lipiodol with hepatic artery injection(Method A) and B-ultrasound guided percutaneous puncture(Method B) was observed in twenty patients with liver cancer. The radionuclide images showed that the 131I-lipiodol acumulated in tumor mainly. The radioactivity of tumor/liver (T/L)ratio in method A and method B was 3.87 ± 2.77 and 9.15 ± 3.41
the effective half-life of 131I- lipiodol in tumor was 4.7 ± 1.92 days and 6.22 ± 0.61 days
and the radioactivity of lung was 13.19 ± 3.01% and 5.19 ± 2.28% respectively. These results suggested that the 131 I- lipiodol biodistribution in method B is better than method A. Clinical results showed that AFP levels dropped rapidly in 64.3% of the patients with positive AFP.A shrinkage in tumor size was observed in 66.7% of patients. With the transient fever
elevated bilirubin and SGPT in some patients
no other toxicity and adverse reactions were observed.